Ivana Struzinska

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Comparison of protein-based and genetic prognostic markers in a large cohort of primary pulmonary and extrapulmonary small cell neuroendocrine carcinoma.

Comparison of protein-based and genetic prognostic markers in a large cohort of primary pulmonary and extrapulmonary small cell neuroendocrine carcinoma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 30, 2025

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

Journal: Virchows Archiv : an international journal of pathology

Published: October 28, 2025

Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.

Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: February 05, 2025

Integrating clinicopathological and molecular data to assess the biological behavior of uterine inflammatory myofibroblastic tumors.

Integrating clinicopathological and molecular data to assess the biological behavior of uterine inflammatory myofibroblastic tumors.

Journal: Pathology, research and practice

Published: January 30, 2025

The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.

The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: November 02, 2024

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases.

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases.

Journal: Virchows Archiv : an international journal of pathology

Published: October 29, 2024

HER2 Status in Low-grade Serous Ovarian Tumors.

HER2 Status in Low-grade Serous Ovarian Tumors.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: September 04, 2024

TRPS1 expression in 451 tubo-ovarian tumours: a potential prognostic marker for high-grade serous carcinoma.

TRPS1 expression in 451 tubo-ovarian tumours: a potential prognostic marker for high-grade serous carcinoma.

Journal: Pathology

Published: July 04, 2024

Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors.

Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors.

Journal: Virchows Archiv : an international journal of pathology

Published: June 07, 2023

HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.

HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: June 05, 2023

A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.

A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.

Journal: Diagnostic pathology

Published: April 21, 2023

Uterine leiomyoma with RAD51B::NUDT3 fusion: a report of 2 cases.

Uterine leiomyoma with RAD51B::NUDT3 fusion: a report of 2 cases.

Journal: Virchows Archiv : an international journal of pathology

Published: April 07, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026